Eltrombopag Olamine | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Eltrombopag Olamine
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Granules Eltrombopag

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Eltrombopag Olamine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

44 API Suppliers, 20 USDMF, 5 EU WC, 13 NDC API, 33 Listed Suppliers, $ API Reference Price

44 API Suppliers
20 USDMF
5 EU WC
13 NDC API
33 Listed Suppliers
$ API Reference Price

INTERMEDIATES

21 Intermediate Suppliers

21 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

82 FDF Dossiers, 25 FDA Orange Book, 10 Europe, 4 Canada, 16 Australia, 2 South Africa, 25 Listed Dossiers

82 FDF Dossiers
25 FDA Orange Book
10 Europe
4 Canada
16 Australia
2 South Africa
25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 12.5MG ACID, TABLET;ORAL - EQ 25MG ACID, TABLET;ORAL - EQ 50MG ACID, TABLET;ORAL - EQ 75MG ACID

TABLET;ORAL - EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 12.5MG ACID
TABLET;ORAL - EQ 25MG ACID
TABLET;ORAL - EQ 50MG ACID
TABLET;ORAL - EQ 75MG ACID

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 14 SPI Pharma, 5 DKSH, 2 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 BASF, 1 Bioplus Life Sciences, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 10 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 19 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 14 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Coating Systems & Additives, 45 Fillers, Diluents & Binders, 26 Controlled & Modified Release, 22 Direct Compression, 20 Disintegrants & Superdisintegrants, 19 Thickeners and Stabilizers, 18 Solubilizers, 16 Granulation, 15 Taste Masking, 13 Chewable & Orodispersible Aids, 13 Parenteral, 12 Lubricants & Glidants, 11 Film Formers & Plasticizers, 11 Co-Processed Excipients, 8 Topical, 6 API Stability Enhancers, 6 Rheology Modifiers, 5 Coloring Agents, 5 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents

51 Coating Systems & Additives
45 Fillers, Diluents & Binders
26 Controlled & Modified Release
22 Direct Compression
20 Disintegrants & Superdisintegrants
19 Thickeners and Stabilizers
18 Solubilizers
16 Granulation
15 Taste Masking
13 Chewable & Orodispersible Aids
13 Parenteral
12 Lubricants & Glidants
11 Film Formers & Plasticizers
11 Co-Processed Excipients
8 Topical
6 API Stability Enhancers
6 Rheology Modifiers
5 Coloring Agents
5 Emulsifying Agents
5 Empty Capsules
4 Vegetarian Capsules
3 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 27 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
27 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Finished Drug Prices, 14 Annual Reports

1 US Medicaid Prescriptions
6 Finished Drug Prices
14 Annual Reports

MARKET PLACE

13 APIs, 7 FDF Dossiers

13 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

101 US Patents, 7 US Exclusivities, 9 Health Canada Patents

101 US Patents
7 US Exclusivities
9 Health Canada Patents

$ API Ref.Price (USD/KG) : 9,997 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

9 All

01 9Gowling WLG (Canada) LLP

filter Patent Reset all filters

9 All

01 32411468

02 32486697

03 32685831

filter Product Reset all filters

9 All

01 3ELTROMBOPAG OLAMINE

02 6Eltrombopag Olamine

filter Dosage Reset all filters

9 All

01 3TABLET

02 6Tablet

filter Exp Date Reset all filters

9 All

01 32021-05-24

02 32023-05-21

03 32027-08-01

CCSB Eltrombopag

Product Main Page

01

Gowling WLG (Canada) LLP

Eltrombopag

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

Eltrombopag

Brand Name : REVOLADE

Patent Number : 2486697

Filing Date : 2003-05-21

Strength per Unit : 25 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Eltrombopag

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

Eltrombopag

Brand Name : REVOLADE

Patent Number : 2411468

Filing Date : 2001-05-24

Strength per Unit : 25 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling WLG (Canada) LLP

Eltrombopag

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-26

Eltrombopag

Brand Name : REVOLADE

Patent Number : 2685831

Filing Date : 2007-08-01

Strength per Unit : 25 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling WLG (Canada) LLP

Eltrombopag

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

Eltrombopag

Brand Name : REVOLADE

Patent Number : 2486697

Filing Date : 2003-05-21

Strength per Unit : 50 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Gowling WLG (Canada) LLP

Eltrombopag

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

Eltrombopag

Brand Name : REVOLADE

Patent Number : 2411468

Filing Date : 2001-05-24

Strength per Unit : 50 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Gowling WLG (Canada) LLP

Eltrombopag

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-26

Eltrombopag

Brand Name : REVOLADE

Patent Number : 2685831

Filing Date : 2007-08-01

Strength per Unit : 50 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Gowling WLG (Canada) LLP

Eltrombopag

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-06

Eltrombopag

Brand Name : REVOLADE

Patent Number : 2685831

Filing Date : 2007-08-01

Strength per Unit : 75 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-08-01

Date Granted : 2013-11-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Gowling WLG (Canada) LLP

Eltrombopag

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

Eltrombopag

Brand Name : REVOLADE

Patent Number : 2411468

Filing Date : 2001-05-24

Strength per Unit : 75 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2021-05-24

Date Granted : 2008-04-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Gowling WLG (Canada) LLP

Eltrombopag

PharmScience R&D

Not Confirmed

Gowling WLG (Canada) LLP

Canada

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

Eltrombopag

Brand Name : REVOLADE

Patent Number : 2486697

Filing Date : 2003-05-21

Strength per Unit : 75 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-05-21

Date Granted : 2009-01-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!